MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 140 filers reported holding MERSANA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,401,943 | -59.8% | 5,040,900 | +4.2% | 0.01% | -62.9% |
| Q2 2023 | $15,922,004 | +41086.8% | 4,839,515 | +73259.3% | 0.04% | – |
| Q4 2022 | $38,658 | -91.0% | 6,597 | -89.6% | 0.00% | -100.0% |
| Q3 2022 | $430,000 | +68.6% | 63,527 | +15.0% | 0.00% | 0.0% |
| Q2 2022 | $255,000 | +123.7% | 55,249 | +93.7% | 0.00% | – |
| Q1 2022 | $114,000 | +25.3% | 28,525 | +95.0% | 0.00% | – |
| Q4 2021 | $91,000 | -71.4% | 14,630 | -25.5% | 0.00% | -100.0% |
| Q1 2021 | $318,000 | -91.5% | 19,636 | -90.3% | 0.00% | -92.9% |
| Q3 2020 | $3,760,000 | +941.6% | 201,958 | +459.6% | 0.03% | +1300.0% |
| Q3 2018 | $361,000 | -75.5% | 36,090 | -56.3% | 0.00% | -71.4% |
| Q2 2018 | $1,475,000 | – | 82,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |